相关实验视频

Updated: Jun 3, 2025

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

生物材料介导的生物矿物化用于瘤阻断疗法

Chao Sun^1,2, Shuqiang Li², Jianxun Ding^1,3

¹Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, P. R. China.

Nanomedicine (London, England)

|January 13, 2025

概括

生物材料介导的生物矿物化提供了一种新的瘤阻断策略. 这种方法精确地准瘤细胞和线粒体,提高治疗疗效,减少副作用.

科学领域:

生物医学工程生物医学工程
在瘤学瘤学.
材料科学材料科学材料科学

背景情况:

最近的进展突出了生物材料介导的生物矿物化用于瘤治疗.
生物矿物化为针对性瘤抑制提供了对纳米矿物化结构的精确控制.

研究的目的:

探索生物材料介导生物矿物化的潜力,以实现多维瘤封锁.
研究向瘤细胞抑制和亡诱导的机制.

主要方法:

工程化矿化前体分子用于选择性结合瘤细胞膜蛋白.
利用生物矿物质材料破坏瘤细胞膜功能和线粒体能量代谢.

主要成果:

工程分子阻碍了瘤细胞信号传导.
生物矿物质诱导瘤细胞亡,并通过破坏线粒体代谢来降低活力.

结论:

生物材料介导的生物矿物化提供了精确有效的瘤治疗.
这种方法提高了治疗效率,向瘤细胞和线粒体,并减轻了副作用.

关键词:

生物材料是一种生物材料.生物矿物化生物矿物化细胞膜的细胞膜.线粒体中的线粒体.纳米医药是一种纳米医药.有针对性的受体受体.瘤阻塞疗法是一种瘤阻塞疗法.

更多相关视频

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...